Werbung
Werbung
LENZ
LENZ Therapeutics, Inc. Common Stock
14.87
USDGesponsert
-0.37
-2.43%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
14.95
+0.08
+0.54%
LENZ Ergebnisberichte
Positives Überraschungsverhältnis
LENZ übertreffen die 9 der letzten 18Schätzungen.
50%
Nächster Bericht
Datum des nächsten Berichts
09. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.00M
/-$0.99
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-83.99%
/+67.80%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/+115.22%
LENZ Therapeutics, Inc. Common Stock earnings per share and revenue
On 05. Nov. 2025, LENZ reported earnings of -0.59 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 18.10% surprise. Revenue reached 12.50 million, compared to an expected 6.96 million, with a 79.48% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.99 USD, with revenue projected to reach 2.00 million USD, implying an increase of 67.80% EPS, and decrease of -83.99% in Revenue from the last quarter.
FAQ
What were LENZ Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, LENZ Therapeutics, Inc. Common Stock reported EPS of -$0.59, beating estimates by 18.1%, and revenue of $12.50M, 79.48% above expectations.
How did the market react to LENZ Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.46%, changed from $28.05 before the earnings release to $21.47 the day after.
When is LENZ Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09. März 2026.
What are the forecasts for LENZ Therapeutics, Inc. Common Stock's next earnings report?
Based on 8
analysts, LENZ Therapeutics, Inc. Common Stock is expected to report EPS of -$0.99 and revenue of $2.00M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung